Contract Pharma Conference for Android
Conference sessions will address critical issues in outsourcing, including: Macroeconomic Trends Shaping (Bio)Pharma; Investigator Insights: Preparing for an Inspection; The CMO Landscape: Trends Update; Best Practice Approach to Serialization; Building a Sustainable Pharma Supply Chain; Ensuring the Integrity of Your Data at CMOs; GDUFA Regulatory Update; Biopharma Contract Manufacturing Trends; Pharmaceutical Processes: Batch or Continuous: Reality, Myth and Imagination; R&D Outsourcing Panel
Speakers at the event include:
• Peter Stevenson, vice president and general manager of portfolio management in Pfizer’s Global Established Pharma (GEP) division
• Liatte Krueger, senior regulatory drug operations officer, U.S. Dept. of Health and Human Services, FDA
• Jim Miller, founder and president, Pharmsource
• Mathy Stanislaus, assistant administrator in EPA's Office of Land and Emergency Management (OLEM)
• John Avellanet, managing director and principle consultant, Cerulean Associates
• Terri Nataline, principal consultant, regulatory practice, Lachman Consultants
• William Downey, owner, HighTech Business Decisions
• Girish Malhotra, president, Epcot International
• Rob McKean, vice president specialty CMC, U.S., Teva Pharmaceuticals
• Ellie Krasney, associate research fellow in analytical R&D, pharmaceutical sciences, Pfizer Worldwide R&D
• Dr. Arindam Bose, partner, AbioligicsB
The meeting includes: Breakfast, Refreshment Breaks, Lunch, and the Networking Cocktail Reception.